Basic info
Industry
biotechnology research
Sectors
clinical trial
antibody
IO
Health Care
Immunology
drug discovery
Immunotherapy
CMC
Medical
Biopharma
IND
Cancer
Date founded
2016
Funding rounds raised
Total raised
$30M
from 4 investors over 4 rounds
L
Lyvgen Biopharma raised $10M on February 23, 2021
Investors: 上海自贸区股权投资基金管理有限公司, Chengwei Capital and IDG Capital Partners
L
Lyvgen Biopharma raised $30M on July 18, 2018
Investors: 6 Dimensions Capital